Please try another search
Avacta Group Plc develops cancer drugs and in vitro diagnostics in the United Kingdom, France, North America, South Korea, rest of Europe, and internationally. The company operates through Diagnostics and Therapeutics segments. It provides its proprietary Affimer and pre|CISION technology platforms, which is used to deliver a portfolio of differentiated th therapeutic and diagnostic products that addresses various markets. The company develops AVA6000, a peptide drug conjugate form of doxorubicin that is in Phase I clinical trial to treat locally advanced or metastatic solid tumour; AVA3996, a tumor-activated proteasome inhibitor based on Velcade; and AVA032, a bispecific molecule which is in pre-clinical trials that regulates the activation and proliferation of immune cells. It also develops AVA-028-PD-L1 Affimer/ImmunoCytokines; AVA-021 - PD-L1 Affimer/LAG-3 Affimer; and TMAC platform that utilizes the proprietary pre|CISION substrate to provide for the selective release of a drug moiety by FAPa. The company has a collaboration agreement with LG Chem for developing and commercializing Affimer based therapeutics. Avacta Group Plc was incorporated in 2003 and is based in Wetherby, the United Kingdom.
Name | Age | Since | Title |
---|---|---|---|
Trevor John Nicholls | 68 | 2013 | Independent Non-Executive Director |
Paul Andrew Fry | 58 | 2020 | Independent Non-Executive Director |
Krishna Komanduri | - | 2021 | Member of Scientific Advisory Board |
Eliot Richard Forster | 58 | 2018 | Independent Non-Executive Chairman |
Mark A. Goldberg | 70 | 2021 | Independent Non-Executive Director |
Stephane Champiat | - | 2021 | Member of Scientific Advisory Board |
Shaun Edward Chilton | 57 | 2023 | Non-Executive Director |
James Spicer | - | 2021 | Member of Scientific Advisory Board |
Tony Gardiner | 53 | 2016 | CFO, Company Secretary & Executive Director |
Christina Marie Coughlin | 54 | 2022 | CEO, Interim Chief Medical Officer and Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review